Literature DB >> 33620082

Morphological changes in mouse ovary due to hormonal hypersecretion and matrix metalloproteinase -2 activity.

Sang-Hwan Kim1, Jong-Taek Yoon1,2.   

Abstract

We analyzed whether aberrant gonadotropin secretion affects the morphological remodeling of murine ovarian tissues facilitated by activated matrix metalloproteinase (MMP) enzymes. Six mice were intraperitoneally injected with 5 IU of pregnant mare serum gonadotropin (PMSG) or human chorionic gonadotropin (HCG) every two days after estrus synchronization. Morphology and expression of various MMPs were assessed following the successful induction of hormonal secretion in these tissues. HCG treatment, but not PMSG treatment, resulted in the expanded production of granulose second follicular cells. In addition, the number of developing follicular cells in the HCG group increased compared with that in the PMSG group. Ovarian diameters were also very small in the PMSG group. Immunohistochemistry revealed decreased MMP-2 protein activity in the HCG group and increased MMP-2 activity in the PMSG group. Activity was particularly high in theca and granulose cells of the PMSG group, but only partial activity was observed in the theca cells of the HCG group. Vascular endothelial growth factor activity was increased in both the external and internal theca cell walls in the PMSG group while the HCG group showed high overall expression of this protein in the internal theca cells. These data indicate that follicular cell activity and remodeling of the ovaries differ based on the type of secretory hormone signals they receive. Inappropriate gonadotropin secretion may induce functional changes in the ovaries, and follicular remodeling may be facilitated by the activity of various MMPs.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33620082     DOI: 10.14670/HH-18-318

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  32 in total

Review 1.  Oocyte control of ovarian follicular development and function in mammals.

Authors:  J J Eppig
Journal:  Reproduction       Date:  2001-12       Impact factor: 3.906

2.  Differential FSH exposure in preantral follicle culture has marked effects on folliculogenesis and oocyte developmental competence.

Authors:  I Adriaens; R Cortvrindt; J Smitz
Journal:  Hum Reprod       Date:  2004-02       Impact factor: 6.918

Review 3.  Ovarian actions of estrogen receptor-β: an update.

Authors:  Ann E Drummond; Peter J Fuller
Journal:  Semin Reprod Med       Date:  2012-01-23       Impact factor: 1.303

4.  Attenuation of astroglial reactivity by interleukin-10.

Authors:  V Balasingam; V W Yong
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

Review 5.  Cyclic changes in the matrix metalloproteinase system in the ovary and uterus.

Authors:  T E Curry ; K G Osteen
Journal:  Biol Reprod       Date:  2001-05       Impact factor: 4.285

Review 6.  Endocrinology of the ovary.

Authors:  E Y Adashi
Journal:  Hum Reprod       Date:  1994-05       Impact factor: 6.918

Review 7.  Impact of gene polymorphisms of gonadotropins and their receptors on human reproductive success.

Authors:  Livio Casarini; Daniele Santi; Marco Marino
Journal:  Reproduction       Date:  2015-09-14       Impact factor: 3.906

Review 8.  Luteinizing hormone and human chorionic gonadotropin: origins of difference.

Authors:  Janet Choi; Johan Smitz
Journal:  Mol Cell Endocrinol       Date:  2013-12-21       Impact factor: 4.102

9.  Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.

Authors:  B Banaszewska; R Z Spaczyński; M Pelesz; L Pawelczyk
Journal:  Rocz Akad Med Bialymst       Date:  2003

10.  Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance.

Authors:  A Dierich; M R Sairam; L Monaco; G M Fimia; A Gansmuller; M LeMeur; P Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.